The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation.
复制标题
DOI:
10.1016/j.ijrobp.2009.06.059
复制
发表时间:
2009-11-01
影响因子:
7
通讯作者:
Robbins, Mike E.
中科院分区:
文献类型:
--
作者:
Ramanan, Sriram;Kooshki, Mitra;Zhao, Weiling;Hsu, Fang-Chi;Riddle, David R.;Robbins, Mike E.
Whole-brain irradiation (WBI) leads to cognitive impairment months to years after radiation. Numerous studies suggest that decreased hippocampal neurogenesis and microglial activation are involved in the pathogenesis of WBI-induced brain injury. The goal of this study was to investigate whether administration of the peroxisomal proliferator-activated receptor (PPAR)α agonist, fenofibrate, would prevent the detrimental effect of WBI on hippocampal neurogenesis. 129S1/SvImJ wild-type (WT) and PPARα knock-out (KO) mice that were fed either regular or 0.2% w/w fenofibrate-containing chow received either sham irradiation or WBI (10 Gy single dose of 137Cs γ rays). Mice were injected i.p. with bromodeoxyuridine (BrdU) to label the surviving cells at 1 month post-WBI and the newborn neurons were counted at 2 months post-WBI using BrdU/NeuN double-immunofluorescence. Proliferation in the sub-granular zone (SGZ) and microglial activation were measured at 1 week and 2 months post-WBI using Ki-67 and CD68 immunohistochemistry, respectively. WBI led to a significant decrease in the number of newborn hippocampal neurons 2 months post-WBI. Fenofibrate prevented this decrease by promoting the survival of newborn cells in the dentate gyrus (DG). In addition, fenofibrate treatment was associated with decreased microglial activation in the DG following WBI. The neuroprotective effects of fenofibrate were abolished in the KO mice, indicating a PPARα-dependent mechanism(s). These data highlight a novel role for PPARα ligands in improving neurogenesis following WBI, and offer the promise of improving the quality of life for brain cancer patients receiving radiotherapy.
登录
查看更多内容
影响因子:
82.9
作者:
Eriksson, PS;Perfilieva, E;Gage, FH
通讯作者:
Gage, FH
影响因子:
7.8
作者:
Bauer, S;Patterson, PH
通讯作者:
Patterson, PH
影响因子:
3
作者:
Grabacka, M;Placha, W;Slominski, A
通讯作者:
Slominski, A
DOI:
10.1073/pnas.2234031100
发表时间:
2003-11-11
影响因子:
11.1
作者:
Ekdahl, CT;Claasen, JH;Lindvall, O
通讯作者:
Lindvall, O
影响因子:
3.4
作者:
Fan, Yang;Liu, Zhengyan;Liu, Jialing
通讯作者:
Liu, Jialing